Showing results (111-120 of 486) with videos related to
Sort By:
Pageof 49
Annals of Hematology|July 18, 2019
Effects of rigosertib on the osteo-hematopoietic niche in myelodysplastic syndromesEkaterina Balaian, Heike Weidner, Manja Wobus, et al.Clinical Lymphoma, Myeloma & Leukemia|June 17, 2022
Impact of Lenalidomide Treatment on Overall Survival in Patients With Lower-Risk, Transfusion-Dependent Myelodysplastic SyndromesValeria Santini, Aristoteles Giagounidis, Christopher G Pelligra, et al.Oncotarget|September 12, 2015
Pre-transplant weight loss predicts inferior outcome after allogeneic stem cell transplantation in patients with myelodysplastic syndromeAleksandar Radujkovic, Natalia Becker, Axel Benner, et al.Leukemia|June 16, 2021
Investigation of measurable residual disease in acute myeloid leukemia by DNA methylation patternsTanja Božić, Chao-Chung Kuo, Jan Hapala, et al.Leukemia Research|June 22, 2016
Effects of a home-based exercise program on physical capacity and fatigue in patients with low to intermediate risk myelodysplastic syndrome-a pilot studyMarkus K Schuler, Leopold Hentschel, Julia Göbel, et al.Journal of Clinical Medicine|September 28, 2019
The Evolving Landscape of Biomarkers for Anti-PD-1 or Anti-PD-L1 TherapyAntje Tunger, Ulrich Sommer, Rebekka Wehner, et al.Cancers|November 27, 2021
Risk Stratification, Measurable Residual Disease, and Outcomes of AML Patients with a Trisomy 8 Undergoing Allogeneic Hematopoietic Stem Cell TransplantationDonata Backhaus, Madlen Jentzsch, Lara Bischof, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2008
Gemtuzumab ozogamicin as part of reduced-intensity conditioning for allogeneic hematopoietic cell transplantation in patients with relapsed acute myeloid leukemiaMartin Bornhäuser, Thomas Illmer, Uta Oelschlaegel, et al.British Journal of Haematology|December 10, 2009
188Re anti-CD66 radioimmunotherapy combined with reduced-intensity conditioning and in-vivo T cell depletion in elderly patients undergoing allogeneic haematopoietic cell transplantationAnett Lauter, Annette Strumpf, Uwe Platzbecker, et al.Blood|May 31, 2002
Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosisChristian Thiede, Christine Steudel, Brigitte Mohr, et al.Pageof 49